113 related articles for article (PubMed ID: 38340989)
1. Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine/crack user disorder: A randomized controlled clinical trial.
Junior MSC; Bezerra AG; Curado DF; Gregório RP; Galduróz JCF
Pharmacol Biochem Behav; 2024 Apr; 237():173725. PubMed ID: 38340989
[TBL] [Abstract][Full Text] [Related]
2. Effects of biperiden on the treatment of cocaine/crack addiction: a randomised, double-blind, placebo-controlled trial.
Dieckmann LH; Ramos AC; Silva EA; Justo LP; Sabioni P; Frade IF; de Souza AL; Galduróz JC
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1196-202. PubMed ID: 24974353
[TBL] [Abstract][Full Text] [Related]
3. Biperiden (an M1 antagonist) reduces memory consolidation of cocaine-conditioned place preference.
Zacarias MS; Ramos AC; Alves DR; Galduróz JC
Neurosci Lett; 2012 Apr; 513(2):129-31. PubMed ID: 22336140
[TBL] [Abstract][Full Text] [Related]
4. Biperiden (M₁ antagonist) impairs the expression of cocaine conditioned place preference but potentiates the expression of cocaine-induced behavioral sensitization.
Ramos AC; Andersen ML; Oliveira MG; Soeiro AC; Galduróz JC
Behav Brain Res; 2012 May; 231(1):213-6. PubMed ID: 22469627
[TBL] [Abstract][Full Text] [Related]
5. Human electrophysiological correlates of learned irrelevance: effects of the muscarinic M1 antagonist biperiden.
Klinkenberg I; Blokland A; Riedel W; Sambeth A
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1375-85. PubMed ID: 22094124
[TBL] [Abstract][Full Text] [Related]
6. The effect of the muscarinic M
Vingerhoets C; Bakker G; van Dijk J; Bloemen OJN; Wang Y; Chan RCK; Booij J; van Amelsvoort TAMJ
Eur Neuropsychopharmacol; 2017 Sep; 27(9):854-864. PubMed ID: 28689687
[TBL] [Abstract][Full Text] [Related]
7. Effects of biperiden (cholinergic muscarinic m1/m4 receptor antagonist) on ethanol conditioned place preference in mice.
Palombo P; Engi SA; Yokoyama TS; Bezerra AG; Curado DF; Anésio A; Leão RM; Santos PCJL; Cruz FC; Galduróz JCF
Neurosci Lett; 2021 Feb; 745():135551. PubMed ID: 33346074
[TBL] [Abstract][Full Text] [Related]
8. Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.
Bakker C; van Esdonk MJ; Stuurman RFE; Borghans LGJM; de Kam ML; van Gerven JMA; Groeneveld GJ
J Clin Pharmacol; 2021 Nov; 61(11):1466-1478. PubMed ID: 34021607
[TBL] [Abstract][Full Text] [Related]
9. No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.
Gillin JC; Lauriello J; Kelsoe JR; Rapaport M; Golshan S; Kenny WM; Sutton L
Psychiatry Res; 1995 Sep; 58(2):99-105. PubMed ID: 8570773
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study.
Meneses-Gaya C; Crippa JA; Hallak JE; Miguel AQ; Laranjeira R; Bressan RA; Zuardi AW; Lacerda AL
Braz J Psychiatry; 2021; 43(5):467-476. PubMed ID: 33146345
[TBL] [Abstract][Full Text] [Related]
11. Development of tolerance after repeated administration of a selective muscarinic M1 antagonist biperiden in healthy human volunteers.
Salin-Pascual RJ; Granados-Fuentes D; Galicia-Polo L; Nieves E; Gillin JC
Biol Psychiatry; 1993 Feb; 33(3):188-93. PubMed ID: 8448266
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
13. Influence of muscarinic M
Vingerhoets C; Bakker G; Schrantee A; van der Pluijm M; Bloemen OJN; Reneman L; Caan M; Booij J; van Amelsvoort TAMJ
Psychiatry Res Neuroimaging; 2019 Aug; 290():5-13. PubMed ID: 31252222
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants.
Klinkenberg I; Blokland A; Riedel WJ; Sambeth A
Psychopharmacology (Berl); 2013 Feb; 225(4):903-21. PubMed ID: 23052568
[TBL] [Abstract][Full Text] [Related]
15. Effects of biperiden and acute tryptophan depletion and their combination on verbal word memory and EEG.
Borghans LG; Blokland A; Sambeth A
Psychopharmacology (Berl); 2017 Apr; 234(7):1135-1143. PubMed ID: 28210777
[TBL] [Abstract][Full Text] [Related]
16. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation.
Hailwood JM; Heath CJ; Phillips BU; Robbins TW; Saksida LM; Bussey TJ
Neuropsychopharmacology; 2019 May; 44(6):1068-1075. PubMed ID: 30478410
[TBL] [Abstract][Full Text] [Related]
17. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
[TBL] [Abstract][Full Text] [Related]
18. Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers.
Guthrie SK; Manzey L; Scott D; Giordani B; Tandon R
J Clin Psychopharmacol; 2000 Feb; 20(1):77-83. PubMed ID: 10653212
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
20. Biperiden reverses the increase in 50-kHz ultrasonic vocalizations but not the increase in locomotor activity induced by cocaine.
Saldanha TCS; Sanchez WN; Palombo P; Cruz FC; Galduróz JCF; Schwarting RKW; Andreatini R; da Cunha C; Pochapski JA
Behav Brain Res; 2024 Mar; 461():114841. PubMed ID: 38159887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
